🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Dr. Jen-Jane Liu MD discusses the management of muscle invasive #BladderCancer and outlines emerging developments in perioperative systemic therapy. Watch (via UroToday.com): bit.ly/4jE7KEM

The basis for friendship, relationship, partnership - isn’t proximity or time spent together - it’s values. Naval

Fascinating to see so many IMGs from around the world pursue and achieve their dream specialty. Congratulations to all! #UroSoMe #UrologyMatch2025 #AUA The Urology Applicant ⚕ UroResidency

Introducing the Reviewer of the Month Jasper Bash. Dr. Bash is a Men’s Health and Fertility urologist at OHSU in Portland, OR, where he studies the impact of environmental exposures on male fertility.

Postdoc Opportunity – Urology Research at UChicago! 🚨 Join my team to advance Prostate Cancer research! Key roles: clinical research, trials, data management, manuscript & grant writing. 💰 Salary: $61K-$74K (NIH scale) 📍 Location: University of Chicago 📩 Apply: Send CV &

Taking phones off the internet boosts mental health. People were randomly assigned to block mobile internet for 2 weeks. They socialized, exercised, and read more—and became happier, less depressed & anxious, and more focused. Being unglued from devices is good for well-being.

Treating #ProstateCancer differently 🦾 OHSU News became the first hospital in Oregon to offer a new option for treatment, using a robotic-assisted high-intensity focused ultrasound device that destroys the cancerous tissue while minimizing side effects: bit.ly/4cGq7WJ

We're excited to welcome OHSU Knight Cancer Institute to our global community of hospitals offering Focal One. Congratulations on being the first in Oregon to offer Robotic Focal HIFU as an option for prostate cancer patients! Congratulations to Sudhir Isharwal, MD, MBA, FACS and the clinical

Speechless QOL better after cystectomy #AUA2025

Was putting the dishes away this morning & listened to the most amazing podcast w Nishant Patel, MD on BackTable Urology (hosted by DrBagrodia UCSD Urology). All I can say is THANK YOU Nishant for putting such a personal story out there. I’m sure it’s going to be beneficial for many

Robotics Theater Prostate Session standing room only! Booth #355 in the Science & Technology Hall. #AUA25 #Urology

Tired of drowning in clinic notes after hours? Ready to reclaim your evenings? Sarah Hecht, MD gave a phenomenal lecture on boosting efficiency for Young Urologists 📌Filter tasks 📌Busy is a 4 letter word 📌Minimize touches 📌Order of operations is 🔑 Amer. Urol. Assn. #AUA25

The SUO recognized Dr. Roger Li, MD, as the Young Investigator for the 2025 SUO at AUA Meeting. To see more about the award and prior winners, please visit suonet.org/awards/young-i…

FIRST BLADDER TRANSPLANT Historic surgery by USC Urology & UCLA Urology teams opens new paths for non-functioning bladder treatment 👨‍⚕️ Medical Milestone - New option for 'terminal' bladders 🔗 Collaborative Triumph - Result of extensive R&D by USC and UCLA 🔬 Clinical

Watch Jen-Jane Liu MD discuss the management of muscle invasive #BladderCancer and outline emerging developments in perioperative systemic therapy in an interview with UroToday.com. #OHSUResearch: bit.ly/4kEdPRX

Dads are spending 3-4x as much time with their kids as their dads did with them. When father figures are engaged, kids show better cognitive development, boys have fewer behavioral problems, and girls have fewer emotional problems. Every child deserves strong parental bonds.

Amir Patel, MD, (Amir Patel, MD) highlights interim findings from a study evaluating onabotulinumtoxinA injection at the time of HoLEP. NM Urology urologytimes.com/view/amir-pate…

Johnson & Johnson receives U.S. FDA Priority Review for TAR-200 NDA in high-risk non-muscle invasive bladder cancer jnj.com/media-center/p…

J&J receives U.S. FDA Priority Review for TAR-200 in high-risk NMIBC Phase 2b SunRISe-1 study #AUA25 ✅82.4 % CR rate ☑️ 52.9 % cancer-free at least one year after CR jnj.com/media-center/p…

The people who dominate the conversation often have the least to say. Being the loudest voice in the room doesn’t gain respect. It crowds out the contributions of those who speak at a lower volume. It’s better to leave people wanting to hear more than wishing they’d heard less.